Drug Classification List Medications

Blood Pressure Medication Recalled Because Of Cancer Risk

Common High Blood Pressure Medication Recalled Over Carcinogens

The FDA reports that the affected capsules contain nitrosamine impurities, specifically called “N-Nitroso Prazosin impurity C” in the official report, that go beyond the safety limit set by the Carci...

· 1d

Blood Pressure Medication Recalls: See Which Meds Were Recalled

· 1d · on MSN

FDA warns this blood pressure medication may have cancer-causing chemicals. See recall list

· 1d

Blood pressure medication recalled over potential carcinogen: What to know

Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially carcinogenic chemical that exceeds the “acceptable intake limit.”

· 1d

Over half-million bottles of blood pressure medication have been recalled: Here’s why

· 1h

FDA recalls blood pressure medication over cancer risk, impacting half a million bottles

· 1d

FDA Recalls Blood Pressure Drug Over Cancer Risk

The FDA classified the affected batches as a Class II risk, meaning use could cause temporary or reversible health effects—and, in rare cases, more serious consequences, as reported by the AP.

· 1d

Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride

· 15h

FDA: Blood Pressure Medication Recall Yet Again For Cancer Concerns

JD Supra

GLP-1 Weight-Loss Drugs Off Shortage List; Deadlines to Stop Compounding

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled and off-label indications for use. GLP-1 is a hormone that ...

Military Officers Association of America

Speaking Out on TRICARE GLP-1 Drug Changes

Hundreds of you have shared your story with MOAA. Here’s how you can join our fight to protect the TRICARE For Life benefit.